Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Authors:
  • YCYuanzhong Chen
    Yuanzhong Chen
  • SWShaoyuan Wang
    Shaoyuan Wang
  • FYFeng’E Yang
    Feng’E Yang
  • JZJing Zheng
    Jing Zheng
  • DFDanhui Fu
    Danhui Fu
  • JLJia Lin
    Jia Lin
  • XLXiaofan Li
    Xiaofan Li
  • NLNainong Li
    Nainong Li

Abstract
No abstract available

This publication has 30 references indexed in Scilit: